Clinical trials
Diabetes Mellitus clinical trials
Below are recruiting diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 887 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07585994Recruiting
Probiotic supplement for long-standing type 1 diabetes
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
AmsterdamAges 18 years+ - NCT07614230RecruitingPhase 4
SGLT2 drugs and heart artery health in diabetes
This study tests whether a diabetes medication called SGLT2 inhibitors can slow the buildup of plaque in heart arteries. Researchers will use special CT scans to track changes in your coronary arteries over time.
Beijing, Beijing MunicipalityAges 18–78 - NCT07649967Recruiting
Mixed Reality Balance and Movement Tests for Type 2 Diabetes
This study tests whether new virtual-reality-based balance and movement tests work well for people with type 2 diabetes. Researchers want to see if these tests can safely and accurately measure how well people can move and balance.
Konya, SelcukluAges 18–65 - NCT07655076RecruitingEarly Phase 1
Smart insulin delivery study for type 1 diabetes
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Toronto, OntarioAges 18 years+ - NCT07566845Enrolling by invitation
High-intensity exercise for women after gestational diabetes
This study tests whether high-intensity interval training (HIIT)—short bursts of intense exercise—can help women who had gestational diabetes during pregnancy stay healthy and prevent type 2 diabetes. You'll do supervised workouts over several months while researchers track your health.
Odense, Region SyddanmarkAges 25–45 - NCT07452913Enrolling by invitationPhase 4
Comparing Diabetes Drug Combinations in Newly Treated Adults
This trial compares two different combinations of diabetes pills (metformin plus empagliflozin with either sitagliptin or linagliptin) in people with type 2 diabetes who have not been treated before. It aims to see which combination works better and is safer for controlling blood sugar.
Karachi, SindhAges 30–55 - NCT07387393Enrolling by invitation
PILI Pasifika Lifestyle Program for Native Hawaiian and Pacific Islander adults
This study tests a 3-month lifestyle program called PILI Pasifika, which includes healthy eating, physical activity, and support for social needs like housing or food. It aims to help Native Hawaiian and Pacific Islander adults with conditions like diabetes or high blood pressure improve their health in real-world settings.
Fayetteville, ArkansasAges 18 years+ - NCT05869734Enrolling by invitation
Conservative care to improve urinary symptoms and sleep in diabetes
This study looks at a non-surgical (“conservative”) approach to help women with diabetes who have bladder-related urinary symptoms and poor sleep. It aims to see whether these symptoms improve at the same time, helping quality of life.
New Taipei CityAges 20–79 - NCT06217302RecruitingPhase 3
Sotagliflozin for kidney protection in type 1 diabetes
This study tests whether sotagliflozin (a pill that helps control blood sugar and protects the kidneys) can slow down kidney function decline in people with type 1 diabetes and diabetic kidney disease. You may qualify if you have had type 1 diabetes for at least 8 years, have moderate kidney damage, and are on standard treatments.
Stanford, CaliforniaAges 18–75 - NCT06688903Recruiting
App and community support for type 2 diabetes
This trial tests whether a smartphone app combined with community programs can help people with type 2 diabetes better manage their blood sugar. You may be able to join if your most recent blood sugar check shows a result of 6.5% or higher and you are physically able to exercise.
SingaporeAges 21 years+ - NCT07339852Recruiting
Pharmacist-led diabetes care in community pharmacies
This study tests whether a pharmacist-led program can help people with type 2 diabetes who are not meeting their blood sugar goals. The goal is to see if working with a pharmacist in your local pharmacy can improve your diabetes management.
Edmonton, AlbertaAges 18 years+ - NCT06605287Recruiting
Long-term diabetes progress after Supaglutide treatment
This study follows up with people who were in an earlier Supaglutide trial to see how their diabetes is doing after treatment. It helps researchers understand if the medication's effects last over time.
NanjingAges 18–75 - NCT05930210RecruitingPhase 3
Study gel treatment for diabetic foot ulcers that won’t heal
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
Miami, FloridaAges 18 years+ - NCT06447467Recruiting
Heart failure recovery in diabetics and non-diabetics
This study looks at how people with and without diabetes recover from acute heart failure (a sudden worsening). It aims to compare short-term outcomes in the hospital.
SohagAges 18 years+ - NCT07186660RecruitingPhase 2
Studying a new insulin sensitizer for type 1 diabetes
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Charlottesville, VirginiaAges 18–45 - NCT05502016Recruiting
Diabetes education for Marshallese families
This study tests a family-based diabetes self-care education program offered at local places in the Marshallese community. It may help improve how people manage type 2 diabetes day to day by involving family members.
Springdale, ArkansasAges 18 years+ - NCT06957093Recruiting
AI‐assisted diabetes care vs standard management
This study tests whether an AI‐powered digital health platform can help people with type 2 diabetes better manage their blood sugar. If you use a smartphone and have had diabetes for at least a year, this may be a convenient way to receive extra support.
Changchun, JilinAges 18–75 - NCT06582472Recruiting
Early eye changes and diabetes trial
This study looks at early damage to the retina (the back of the eye) in people with type 2 diabetes, even before vision problems start. It aims to find new ways to detect and treat diabetic eye disease early.
Milan, Italy/milanAges 40–80 - NCT07129915Recruiting
Can a smartphone nudge improve diabetes self-management?
This trial tests whether using a nudge-based digital tool (on your smartphone) helps people with type 2 diabetes make better decisions and manage their condition more effectively at home.
Xiamen, FujianAges 18 years+ - NCT07351786Recruiting
Newer diabetes drugs and eye protection study
This trial is looking at whether newer diabetes drugs (like SGLT2 inhibitors and DPP-4 inhibitors) can help protect the eyes of people with long-standing type 2 diabetes. The study focuses on preventing or slowing diabetic retinopathy, a common eye complication.
AlexandriaAges 25 years+ - NCT07222332RecruitingPhase 3
Baricitinib for new type 1 diabetes to save insulin-making cells
This trial tests if baricitinib, a pill that calms the immune system, can protect the remaining insulin-making cells in people newly diagnosed with type 1 diabetes. If it works, you might keep making some of your own insulin longer.
Aurora, ColoradoAges 1–35 - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30 - NCT04286399RecruitingPhase 4
Prevention trial for heart outcomes in people with type 2 diabetes
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
SingaporeAges 40 years+ - NCT04783441Recruiting
Continuous glucose sensor study after kidney transplant
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
Sacramento, CaliforniaAges 18 years+
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus?
- Yes. Clin2 currently lists 887 recruiting diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.